• 

  July 26, 2025

  Precision Cancer Medicines and Breast Cancer

  Charles H. Weaver, MD

• 

  March 4, 2021

  Update on PARP Inhibitors & Other Precision Cancer Medicines for Ovarian Cancer

  Charles H. Weaver, MD

• 

  February 21, 2021

  PARP Inhibitors Slow Spread of Breast Cancer Caused by Inherited BRCA Mutations

  Charles H. Weaver, MD

• 

  September 30, 2020

  PARP Inhibitors – Effective in Men with BRCA-Mutant Prostate Cancer

  Charles H. Weaver, MD

• 

  September 23, 2020

  Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer

  Charles H. Weaver, MD

• 

  August 22, 2020

  Treatment & Management of Ovarian Cancer

  Charles H. Weaver, MD

• 

  September 7, 2019

  Rubraca Significantly Improves Survival Ovarian Cancer

  Charles H. Weaver, MD